Posterizan, ointment 25 g

Pharmacotherapeutic group: immunostimulant

Pharmacodynamics:

Antigens of cell walls and products of metabolism of E. coli in contact with the rectal mucosa and skin anogenital area increase local resistance to the effects of pathogenic microflora.

The drug stimulates the T-lymphocytic system of cellular immunity increases phagocytic activity of leukocytes and reticuloendothelial system cells nonspecific immune factors reduce vascular exudation during inflammation normalizes the permeability and tone of blood vessels stimulates regeneration of damaged tissues.

Indications

Posterisan® ointment is prescribed to adults for the following diseases:

– anal itching of discharge and burning in the anal area due to hemorrhoidal diseases;

– anal fissures;

– eczema.

Pharmacological effect

Pharmacotherapeutic group: immunostimulating agent

Pharmacodynamics:

Cell wall antigens and metabolic products of E. coli upon contact with the rectal mucosa and. skin of the anogenital area increases local tissue resistance to the effects of pathogenic microflora.

The drug stimulates the T-lymphocyte system of cellular immunity, increases the phagocytic activity of leukocytes and cells of the reticuloendothelial system, nonspecific immune factors reduces vascular exudation during inflammation, normalizes the permeability and tone of blood vessels, stimulates the regeneration of damaged tissues.

Special instructions

Contains lanolin: may cause local skin reactions (eg contact dermatitis). When using ointment and latex condoms simultaneously, the strength of the latter may be impaired, which reduces their reliability.

Composition

1 g of ointment contains:

active ingredient:

standardized suspension of E. coli bacteria 166.70 mg, (3.3 x 108 ± 25% (2.475 x 108 – 4.125 x 108) micro cells of E. coli, inactivated and preserved in 3.3 mg of liquefied phenol);

excipients: liquefied phenol 3.30 mg (as part of SCR) (corresponding to the content of solid phenol 3.0 mg), lanolin 166.60 mg, petroleum jelly 666.70 mg.

Contraindications

Hypersensitivity to the active substance or other components of the drug, children under 18 years of age.

Side Effects

Posterisan® has no side effects even with long-term use.

Phenol is used as a preservative in the drug; therefore, allergic reactions are possible in patients with hypersensitivity to this component, in the event of which the use of the drug should be discontinued.

Overdose

No cases of overdose have been reported. If accidentally swallowed (in children), gastrointestinal symptoms (abdominal pain, nausea) may occur.

Storage conditions

In a dry place, protected from light, at a temperature of 0 to 25 ° C.

Keep out of the reach of children.

Transportation

At temperatures from 0 to 25 °C.

Shelf life

3 years.

Do not use after the expiration date indicated on the package.

Manufacturer

Dr. Kade, Germany